Price
22.82
+3.07%52W Range
Market Cap
₹34.22 Cr
Traded: ₹0.05 Cr (0.14%) 0.0x
Free Float: ₹22.79 Cr (0.22% of FF traded)
Volume · 60D trend
21.73 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +6.0% | +19.0% | +7.0% | -- | -3.0% | Decelerating |
| ROE | +6.0% | +5.0% | +3.0% | -- | -- | Decelerating |
| Return | -- | -1.0% | -16.0% | -82.0% | -- | Decelerating |
| Profit | +21.0% | +32.0% | -17.0% | -- | +59.0% | Stable |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 26 | 34 | 26 | 31 | 28 | 38 | 32 | 26 | 26 | 30 | 23 | 23 | 23 | 24 |
| Expenses | 25 | 35 | 24 | 28 | 26 | 37 | 29 | 27 | 24 | 29 | 21 | 22 | 22 | 24 |
| Operating Profit | 1 | -1 | 2 | 2 | 2 | 1 | 2 | -0 | 2 | 1 | 2 | 1 | 1 | 1 |
| OPM % | 5.4% | -3.2% | 6.4% | 8.1% | 7.4% | 3.5% | 7.3% | -1.0% | 5.9% | 3.4% | 8.3% | 5.4% | 6.2% | 2.2% |
| Other Income | 0 | -1 | 0 | 0 | 0 | 0 | -0 | 3 | 1 | 0 | 0 | 1 | -0 | 1 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | -2 | 1 | 2 | 1 | 0 | 0 | 1 | 1 | -0 | 1 | 1 | -0 | -0 |
| Tax % | 23.5% | -13.7% | 23.0% | 25.3% | 25.6% | -34.2% | 6.1% | -6.3% | 25.0% | -28.6% | 16.4% | 7.4% | -23.5% | -131.3% |
| Net Profit | 1 | -2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | -0 | 1 | 1 | -0 | 0 |
| Exceptional Items | -- | -1 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 |
| EPS (Rs) | 0.3 | -1.3 | 0.4 | 0.8 | 0.7 | 0.4 | 0.3 | 1.0 | 0.7 | -0.1 | 0.6 | 0.7 | -0.1 | 0.1 |
| Sales Growth (YoY) | -- | -12.1% | -18.8% | 15.8% | 9.2% | 26.6% | 37.7% | 14.0% | 11.3% | 24.5% | -6.3% | -4.0% | -1.3% | -1.1% |
| Sales Growth (QoQ) | -- | 30.4% | -16.0% | 9.1% | -26.5% | 20.6% | 19.8% | 2.9% | -14.8% | 31.1% | -0.8% | 0.4% | -4.7% | -- |
| OP Growth (YoY) | -31.4% | -180.0% | -29.3% | 1018.5% | 36.2% | 32.4% | 22.1% | -121.4% | 6.3% | 92.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | 231.5% | -165.9% | -33.9% | 19.8% | 53.3% | -41.8% | 959.3% | -117.8% | 49.0% | -46.3% | 50.8% | -11.9% | 169.8% | -- |
| Profit Growth (YoY) | -- | -311.0% | 150.0% | 13.0% | 46.0% | 486.0% | -54.0% | 33.0% | 800.0% | -217.0% | -53.0% | -4.0% | -142.0% | -80.0% |
| EPS Growth (YoY) | -- | -452.6% | 31.0% | -24.2% | -2.9% | 480.0% | -48.2% | 33.8% | 638.5% | -266.7% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -452.6% | -49.3% | 10.3% | 79.0% | 31.0% | -70.7% | 41.4% | 800.0% | -117.9% | -24.3% | 669.2% | -316.7% | -- |
| OP Margin | -- | -3.2% | 6.4% | 8.1% | 7.4% | 3.5% | 7.3% | -1.0% | 5.9% | 3.4% | 8.3% | 5.4% | 6.2% | 2.2% |
| Net Margin | -- | -6.0% | 2.2% | 3.7% | 3.6% | 1.3% | 0.9% | 3.8% | 2.7% | -0.3% | 2.4% | 3.2% | -0.6% | 0.3% |
| Material Cost % | -- | 99.0% | 86.0% | 86.0% | 84.0% | 86.0% | 85.0% | 91.0% | 86.0% | 85.0% | 83.0% | 85.0% | 85.0% | 85.0% |
| Employee Cost % | -- | 1.0% | 4.0% | 2.0% | 3.0% | 2.0% | 2.0% | 3.0% | 3.0% | 2.0% | 3.0% | 3.0% | 3.0% | 3.0% |
| P/S | 0.30 | 0.28 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 163.00 | 46.66 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 0.61 | 0.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on 12th August, ....
Outcome of Board Meeting held on 10.08.2026
Un-Audited Financial Results for the quarter ended on June 30, 2026 along with Limited Review Report on said results by the Statutory Auditor of the Company
The Board took on record Resignation of M/s. Shah Kailash and Associates LLP, Chartered Accountant, FRN: 109647W as Statutory Auditor of the Company with effect from 10th August, 2026
The Board of Directors inter-alia has approved the Appointment of M/s. Prit Agrawal & CO., Chartered Accountant having FRN No. 152249W as an Internal Auditor for the financial year 2026-27.
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve un-audited standalone financial ....
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from KFin Technologies Limited- Company''s Registrar ....
Please find the attached Credit rating assigned by CRISIL Rating.
Outcome of Board Meeting held on 02.07.2026
Please find the attachment for Intimation of Forfeiture of Upfront Consideration and Lapse of Warrants
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect ....
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published regarding extract ....
In compliance with the Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with relevant Circular(s) issued by SEBI in this regard, please find ....
Outcome of Board Meeting held on 30.05.2026
Financial Result for Quarter and Year ended 31.03.2026
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Financial Result, which it ....
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve financial result for the Quarter ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
This is with reference to your email dated 15th April, 2026 and Letter No. L/SURV/ONL/PV/APJ/ 2026-2027 / 3730 received from BSE seeking clarification regarding the significant movement ....
The Exchange has sought clarification from Trident Texofab Ltd on April 15, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from KFin Technologies Limited- Company''s Registrar ....
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect ....
We wish to inform you that pursuant to Schedule IV of the Companies Act, 2013 and Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Separate ....
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on February 14, ....
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Earnings Presentation for the quarter and Nine months ....
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Statement of Deviation or Variation, along with ....
The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and Nine months ended on December 31, 2025 along with Limited Review Report
The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and Nine months ended on December 31, 2025 along with Limited Review Report.
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Un-Audited Fincnail Result ....
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from KFin Technologies Limited- Company''s Registrar ....
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect ....
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on November 15, ....
Earnings Presentation for the quarter and Half year ended September 30, 2025
The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and half year ended on September 30, 2025 along with Limited Review ....
The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and half year ended on September 30, 2025 along with Limited Review ....
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Un-Audited Financial result ....
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from KFin Technologies Limited- Company''s Registrar ....
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect ....
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting ....
Proceeding and Outcome of 17th Annual General Meeting (AGM) of the members of the Company.
Please find attached copies of newspaper advertisements published in the Financial Express (English) and Financial Express (Gujarati), regarding notice of 17th Annual General Meeting and ....
Annual Report for FY 2025
The 17th Annual General Meeting ("AGM") of the Company will be held on Thursday, September 25, 2025 at 04:00 p.m. IST through Video Conferencing / Other Audio Visual Means
Pursuant to Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on August 28, 2025 in accordance with relevant Circular issued by SEBI ....
The Board, on the recommendation of the Audit Committee, has approved the appointment of M/s. PAAA & Associates, Cost Accountants, (Firm Registration No. 006283) as the Cost Auditors of ....
Pursuant to section 91 of Companies Act, 2013 and Regulation 42 of SEBI (LODR) Regulation, 2015, the Register of Members and Share Transfer books of the Company will remain closed from ....
17th Annual General Meeting (''AGM'') of the Members of Trident Texofab Limited scheduled to be held on Thursday, September 25, 2025 at 04.00 p.m. through Video Conferencing (''VC'')/Other ....
Annual Reports
9Credit Ratings
6Concalls
31Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Oct 2024
31 Oct 2024Jul 2024
31 Jul 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Apr 2023
30 Apr 2023Jan 2023
31 Jan 2023Oct 2022
31 Oct 2022Jul 2022
31 Jul 2022Apr 2022
30 Apr 2022Jan 2022
31 Jan 2022Oct 2021
31 Oct 2021Aug 2021
31 Aug 2021Jul 2021
31 Jul 2021Feb 2021
28 Feb 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Aug 2020
31 Aug 2020Jul 2020
31 Jul 2020Feb 2020
29 Feb 2020Feb 2020
29 Feb 2020Dec 2019
31 Dec 2019Aug 2019
31 Aug 2019Jun 2019
30 Jun 2019Jun 2019
30 Jun 2019